3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
9
Colorectal Neoplasms
5
Breast Neoplasms
5
Neoplasms
4
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Urinary Bladder Neoplasms
2
Stomatitis
2
Rectal Neoplasms
2
Precancerous Conditions
2
Male Urogenital Diseases
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Vascular Diseases
1
Ulcer
1
Thrombocytopenia
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunction, Physiological
1
Radiation-induced Injuries in Patients With Rectal Cancer
1
Radiation Injuries
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Non-melanoma Skin Cancer
1
Neurotoxicity Syndromes
1
Myocardial Ischemia
1
Interventions
Colonoscopy
5
Cholecalciferol
3
Aspirin
3
Selenium
2
Narrow Band Imaging
2
Calcium Carbonate
2
alpha-Tocopherol
1
Walking
1
Vitamin E
1
Ursodeoxycholic Acid
1
Rosuvastatin Calcium
1
Restraint, Physical
1
Occult Blood
1
Metformin
1
Folic Acid
1
Fluorescein
1
Erlotinib Hydrochloride
1
Endoscopy
1
Eicosapentaenoic Acid
1
Eflornithine
1
Diarylheptanoids
1
Contraceptive Devices, Female
1
Colonography, Computed Tomographic
1
Clinical Chemistry Tests
1
Celecoxib
1
Calcium
1
Calcitriol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Adenomatous Polyps
×
Vitamin E
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts